Home › Companies › SOLID BIOSCIENCES INC. › 2024-2025

SOLID BIOSCIENCES INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and SOLID BIOSCIENCES INC.’s Form 8-K, filed June 13, 2025 (Item 5.07 on EDGAR). Page generated October 18, 2026.

6Ballot items
116Asset managers
703Fund votes
June 12, 2025Meeting date

Results at a glance

Meeting of June 12, 2025: 6 items on SOLID BIOSCIENCES INC.’s Form 8-K, filed June 13, 2025: 2 elected · 4 approved.

Material dissent

4. An amendment to the 2020 Plan to increase the number of shares of the Company's common stock available for issuance thereunder by… 79% of votes cast Approved Under 80%

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2024-2025 2025-2026

Explore SOLID BIOSCIENCES INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by SOLID BIOSCIENCES INC.

These tallies are SOLID BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 13, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

SOLID BIOSCIENCES INC. — official shareholder meeting results, meeting held June 12, 2025
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Alexander Cumbo	59,114,835	--	--	3,202,457	6,576,490	95%	Elected	—
Elect Director: Sukumar Nagendran	57,224,221	--	--	5,093,071	6,576,490	92%	Elected	—
2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025	68,872,513	18,770	2,499	--	--	99.9%	Approved	—
3. An amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 120,000,000 to 240,000,000 (the "Share Increase Amendment")	68,589,052	294,679	10,051	--	--	99.5%	Approved	—
4. An amendment to the 2020 Plan to increase the number of shares of the Company's common stock available for issuance thereunder by 9,000,000 shares and amend the evergreen provision	49,491,497	12,816,329	9,466	--	6,576,490	79%	Approved	—
5. The non-binding, advisory vote on the compensation paid to its named executive officers	57,115,409	5,143,882	58,001	--	6,576,490	92%	Approved	—

Source: SOLID BIOSCIENCES INC., Form 8-K, filed with the SEC on June 13, 2025 — read the filing on EDGAR.

How asset managers voted at the SOLID BIOSCIENCES INC. 2024-2025 meeting

Each item below shows how the 116 asset managers that disclosed a SOLID BIOSCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Alexander Cumbo

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 59,114,835WITHHELD: 3,202,457

Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: Election of Class I Directors: Alexander Cumbo

SOLID BIOSCIENCES INC.’s own tally for this item (“Elect Director: Alexander Cumbo”): 59,114,835 for, 3,202,457 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected Alexander Cumbo and Sukumar Nagendran as Class I directors to serve until the 2028 Annual Meeting of Stockholders, each director to hold office until his successor has been duly appointed and qualified.”
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 6,714,916 for, 197,247 withheld.

FOR

FOR: 6,714,916WITHHOLD: 197,247

Largest asset managers voting on “Election of Class I Directors: Alexander Cumbo” at SOLID BIOSCIENCES INC., 2024-2025
Asset manager	For	Withheld	Vote
Fidelity	2,774,326	0	For
Vanguard	2,196,117	0	For
BlackRock	951,045	0	For
FRANKLIN STRATEGIC SERIES	449,300	0	For
Equitable	81,370	0	For
Charles Schwab	68,607	0	For
Dimensional	0	68,178	Withhold
BRIDGEWAY FUNDS INC	0	57,032	Withhold
Goldman Sachs	56,772	0	For
American Century	0	24,082	Withhold
QUANTITATIVE MASTER SERIES LLC	23,214	0	For
Invesco	22,856	0	For
Lincoln Financial	17,800	0	For
Global X	13,208	0	For
Northern Trust	12,707	0	For
Pacific Life	12,295	0	For
AIG/SunAmerica	0	12,140	Withhold
Bridge Builder Trust	9,693	0	For
John Hancock	0	9,389	Withhold
Tema ETF Trust	8,649	0	For
Victory Capital	0	7,687	Withhold
ProShares	0	7,417	Withhold
Voya	5,861	0	For
Nationwide	4,718	0	For
DWS	0	3,588	Withhold

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

2. Elect Director: Sukumar Nagendran

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%

FOR: 57,224,221WITHHELD: 5,093,071

Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: Election of Class I Directors: Sukumar Nagendran

SOLID BIOSCIENCES INC.’s own tally for this item (“Elect Director: Sukumar Nagendran”): 57,224,221 for, 5,093,071 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected Alexander Cumbo and Sukumar Nagendran as Class I directors to serve until the 2028 Annual Meeting of Stockholders, each director to hold office until his successor has been duly appointed and qualified.”
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 5,627,870 for, 1,284,293 withheld.

FORWITHHOLD

FOR: 5,627,870WITHHOLD: 1,284,293

Largest asset managers voting on “Election of Class I Directors: Sukumar Nagendran” at SOLID BIOSCIENCES INC., 2024-2025
Asset manager	For	Withheld	Vote
Fidelity	2,774,326	0	For
Vanguard	2,196,117	0	For
BlackRock	27,444	923,601	Withhold
FRANKLIN STRATEGIC SERIES	449,300	0	For
Equitable	0	81,370	Withhold
Charles Schwab	68,607	0	For
Dimensional	0	68,178	Withhold
BRIDGEWAY FUNDS INC	0	57,032	Withhold
Goldman Sachs	56,772	0	For
American Century	0	24,082	Withhold
QUANTITATIVE MASTER SERIES LLC	0	23,214	Withhold
Invesco	22,856	0	For
Lincoln Financial	0	17,800	Withhold
Global X	13,208	0	For
Northern Trust	0	12,707	Withhold
Pacific Life	0	12,295	Withhold
AIG/SunAmerica	0	12,140	Withhold
Bridge Builder Trust	0	9,693	Withhold
John Hancock	0	9,389	Withhold
Tema ETF Trust	8,649	0	For
Victory Capital	0	7,687	Withhold
ProShares	0	7,417	Withhold
Voya	5,861	0	For
Nationwide	1,354	3,364	Mixed
DWS	0	3,588	Withhold

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

3. 3. An amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares…

Official resultCAPITAL STRUCTUREReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.5% Approved · of votes cast

FOR 99.5%

FOR: 68,589,052AGAINST: 294,679

Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: The approval of an amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 120,000,000 to 240,000,000.

SOLID BIOSCIENCES INC.’s own tally for this item (“3. An amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 120,000,000 to 240,000,000 (the "Share Increase Amendment")”): 68,589,052 for, 294,679 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved an amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 120,000,000 to 240,000,000 (the "Share Increase Amendment").”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 6,912,163 for.

FOR

FOR: 6,912,163

Largest asset managers voting on “The approval of an amendment to the Company's Certificate of Incorporation, as amended, to increase the number” at SOLID BIOSCIENCES INC., 2024-2025
Asset manager	For	Vote
Fidelity	2,774,326	For
Vanguard	2,196,117	For
BlackRock	951,045	For
FRANKLIN STRATEGIC SERIES	449,300	For
Equitable	81,370	For
Charles Schwab	68,607	For
Dimensional	68,178	For
BRIDGEWAY FUNDS INC	57,032	For
Goldman Sachs	56,772	For
American Century	24,082	For
QUANTITATIVE MASTER SERIES LLC	23,214	For
Invesco	22,856	For
Lincoln Financial	17,800	For
Global X	13,208	For
Northern Trust	12,707	For
Pacific Life	12,295	For
AIG/SunAmerica	12,140	For
Bridge Builder Trust	9,693	For
John Hancock	9,389	For
Tema ETF Trust	8,649	For
Victory Capital	7,687	For
ProShares	7,417	For
Voya	5,861	For
Nationwide	4,718	For
DWS	3,588	For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

4. 4. An amendment to the 2020 Plan to increase the number of shares of the Company's common stock available for issuance…

Official resultCOMPENSATIONReported outcome: Approved

79% Approved · of votes cast

FOR 79%AGAINST

FOR: 49,491,497AGAINST: 12,816,329

Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: The approval of an amendment to the Company's Amended and Restated 2020 Equity Incentive Plan to increase the number of shares of our common stock available for issuance thereunder by 9,000,000 shares and amend the evergreen provision.

SOLID BIOSCIENCES INC.’s own tally for this item (“4. An amendment to the 2020 Plan to increase the number of shares of the Company's common stock available for issuance thereunder by 9,000,000 shares and amend the evergreen provision”): 49,491,497 for, 12,816,329 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved an amendment to the 2020 Plan to increase the number of shares of the Company's common stock available for issuance thereunder by 9,000,000 shares and amend the evergreen provision.”
Support: 79% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 457,949 for, 6,454,214 against.

AGAINST

FOR: 457,949AGAINST: 6,454,214

Largest asset managers voting on “The approval of an amendment to the Company's Amended and Restated 2020 Equity Incentive Plan to increase the ” at SOLID BIOSCIENCES INC., 2024-2025
Asset manager	For	Against	Vote
Fidelity	0	2,774,326	Against
Vanguard	0	2,196,117	Against
BlackRock	0	951,045	Against
FRANKLIN STRATEGIC SERIES	449,300	0	For
Equitable	0	81,370	Against
Charles Schwab	0	68,607	Against
Dimensional	0	68,178	Against
BRIDGEWAY FUNDS INC	0	57,032	Against
Goldman Sachs	0	56,772	Against
American Century	0	24,082	Against
QUANTITATIVE MASTER SERIES LLC	0	23,214	Against
Invesco	0	22,856	Against
Lincoln Financial	0	17,800	Against
Global X	0	13,208	Against
Northern Trust	0	12,707	Against
Pacific Life	0	12,295	Against
AIG/SunAmerica	0	12,140	Against
Bridge Builder Trust	0	9,693	Against
John Hancock	0	9,389	Against
Tema ETF Trust	8,649	0	For
Victory Capital	0	7,687	Against
ProShares	0	7,417	Against
Voya	0	5,861	Against
Nationwide	0	4,718	Against
DWS	0	3,588	Against

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

5. 5. The non-binding, advisory vote on the compensation paid to its named executive officers

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 5 wordings of this item as funds reported it.

92% Approved · of votes cast

FOR 92%

FOR: 57,115,409AGAINST: 5,143,882

Details: description as filed, official tally, votes by 116 asset managers

Description as filed by funds: THE APPROVAL OF AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.

SOLID BIOSCIENCES INC.’s own tally for this item (“5. The non-binding, advisory vote on the compensation paid to its named executive officers”): 57,115,409 for, 5,143,882 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the non-binding, advisory vote on the compensation paid to its named executive officers.”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 37 asset managers voting on “THE APPROVAL OF AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.” at SOLID BIOSCIENCES INC., 2024-2025
Asset manager	For	Against	Vote
Fidelity	2,774,326	0	For
Vanguard	2,196,117	0	For
BlackRock	27,444	923,601	Against
FRANKLIN STRATEGIC SERIES	449,300	0	For
Equitable	0	81,370	Against
Charles Schwab	0	68,607	Against
Dimensional	0	68,178	Against
BRIDGEWAY FUNDS INC	0	57,032	Against
Goldman Sachs	0	56,772	Against
American Century	0	24,082	Against
QUANTITATIVE MASTER SERIES LLC	0	23,214	Against
Invesco	0	22,856	Against
Lincoln Financial	17,800	0	For
Global X	13,208	0	For
Northern Trust	0	12,707	Against
Pacific Life	0	12,295	Against
AIG/SunAmerica	0	12,140	Against
Bridge Builder Trust	0	9,693	Against
John Hancock	0	9,389	Against
Tema ETF Trust	8,649	0	For
Victory Capital	0	7,687	Against
ProShares	0	7,417	Against
Voya	0	5,861	Against
Nationwide	1,354	3,364	Mixed
DWS	0	3,588	Against

Fund voting reports, all 37 managers: 5,494,259 for, 1,417,904 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 93 asset managers voting on “THE APPROVAL OF AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.” at SOLID BIOSCIENCES INC., 2024-2025
Asset manager	For	Against	Vote
PERCEPTIVE ADVISORS LLC	10,795,715	0	For
ADAGE CAPITAL PARTNERS GP, L.L.C.	6,699,484	0	For
Siren, L.L.C.	6,402,653	0	For
Commodore Capital LP	5,825,000	0	For
Bain Capital Life Sciences Investors, LLC	5,034,582	0	For
RA CAPITAL MANAGEMENT, L.P.	4,587,613	0	For
Fidelity	2,379,453	0	For
Redmile Group, LLC	1,963,128	0	For
Nantahala Capital Management, LLC	1,803,336	0	For
VR Adviser, LLC	1,480,202	0	For
FRANKLIN ADVISERS INC	1,240,700	0	For
Vestal Point Capital, LP	0	1,188,233	Against
MPM BioImpact LLC	1,185,639	0	For
Alyeska Investment Group, L.P.	0	782,558	Against
BlackRock	29,650	603,256	Against
GEODE CAPITAL MANAGEMENT, LLC	461,394	0	For
Woodline Partners LP	365,828	0	For
Casdin Capital, LLC	0	300,000	Against
State Street	223,360	1,627	For
Citadel	213,479	0	For
BALYASNY ASSET MANAGEMENT L.P.	213,335	0	For
Point72	0	148,075	Against
APIS CAPITAL ADVISORS, LLC	139,995	0	For
Knott David M Jr	0	132,000	Against
Birchview Capital, LP	127,217	0	For

Institutional-manager reports, all 93 managers: 51,393,069 for, 3,871,276 against. Showing the 25 largest; see all in the interactive database.

6. 2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the…

Official resultAUDIT-RELATEDReported outcome: Approved

99.9% Approved · of votes cast

FOR 99.9%

FOR: 68,872,513AGAINST: 18,770

Details: description as filed, official tally, votes by 37 asset managers

Description as filed by funds: The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.

SOLID BIOSCIENCES INC.’s own tally for this item (“2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 68,872,513 for, 18,770 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 37 asset managers below reported 6,911,178 for, 985 against.

FOR

FOR: 6,911,178AGAINST: 985

Largest asset managers voting on “The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered publ” at SOLID BIOSCIENCES INC., 2024-2025
Asset manager	For	Vote
Fidelity	2,774,326	For
Vanguard	2,196,117	For
BlackRock	951,045	For
FRANKLIN STRATEGIC SERIES	449,300	For
Equitable	81,370	For
Charles Schwab	68,607	For
Dimensional	68,178	For
BRIDGEWAY FUNDS INC	57,032	For
Goldman Sachs	56,772	For
American Century	24,082	For
QUANTITATIVE MASTER SERIES LLC	23,214	For
Invesco	22,856	For
Lincoln Financial	17,800	For
Global X	13,208	For
Northern Trust	12,707	For
Pacific Life	12,295	For
AIG/SunAmerica	12,140	For
Bridge Builder Trust	9,693	For
John Hancock	9,389	For
Tema ETF Trust	8,649	For
Victory Capital	7,687	For
ProShares	7,417	For
Voya	5,861	For
Nationwide	4,718	For
DWS	3,588	For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

Largest SOLID BIOSCIENCES INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 77,515,377 shares outstanding at the time of that meeting.

Fund voting reports: top SOLID BIOSCIENCES INC. shareholders by shares voted on “THE APPROVAL OF AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.”, 2024-2025
#	Asset manager	% of shares outstanding
1	Fidelity	3.58%
2	Vanguard	2.83%
3	BlackRock	1.23%
4	FRANKLIN STRATEGIC SERIES	0.58%
5	Equitable	0.10%
6	Charles Schwab	0.09%
7	Dimensional	0.09%
8	BRIDGEWAY FUNDS INC	0.07%
9	Goldman Sachs	0.07%
10	American Century	0.03%

Institutional-manager reports: top SOLID BIOSCIENCES INC. shareholders by shares voted on “THE APPROVAL OF AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.”, 2024-2025
#	Asset manager	% of shares outstanding
1	PERCEPTIVE ADVISORS LLC	13.93%
2	ADAGE CAPITAL PARTNERS GP, L.L.C.	8.64%
3	Siren, L.L.C.	8.26%
4	Commodore Capital LP	7.51%
5	Bain Capital Life Sciences Investors, LLC	6.49%
6	RA CAPITAL MANAGEMENT, L.P.	5.92%
7	Fidelity	3.07%
8	Redmile Group, LLC	2.53%
9	Nantahala Capital Management, LLC	2.33%
10	VR Adviser, LLC	1.91%

Reported SOLID BIOSCIENCES INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

SOLID BIOSCIENCES INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
RA Capital Management, L.P.	15.53%	13D
Perceptive Life Sciences Master Fund Ltd. and affiliated entities	15.40%	DEF14A
Raymond Debbane	12.99%	13G
BCLS II Investco, LP	11.10%	13D
Entities affiliated with RA Capital Management, L.P.	10.42%	DEF14A
Entities affiliated with Bain Capital Life Sciences Investors, LLC	10.37%	DEF14A
Invus Public Equities, L.P. and affiliated entities	9.57%	DEF14A
Commodore Capital Master LP	7.51%	DEF14A
Vestal Point Capital, LP	7.50%	13G
Entities managed by Vestal Point Capital, LP	5.53%	DEF14A

Percentages above are of 77,515,377 shares outstanding, as reported by SOLID BIOSCIENCES INC. on its Form 10-Q dated May 12, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from SOLID BIOSCIENCES INC.’s 10-Q dated May 12, 2025. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At SOLID BIOSCIENCES INC.'s shareholder meeting held June 12, 2025, in the 2024-2025 proxy season, 116 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 703 separate fund positions. On the most widely held item on that ballot — THE APPROVAL OF AN ADVISORY VOTE ON EXECUTIVE COMPENSATION. — SOLID BIOSCIENCES INC.'s filing reports the proposal as approved, with 92% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: SOLID BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 13, 2025.

SOLID BIOSCIENCES INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.